Literature DB >> 11737198

Human synemin gene generates splice variants encoding two distinct intermediate filament proteins.

M Titeux1, V Brocheriou, Z Xue, J Gao, J F Pellissier, P Guicheney, D Paulin, Z Li.   

Abstract

Intermediate filament (IF) proteins are constituents of the cytoskeleton, conferring resistance to mechanical stress, and are encoded by a dispersed multigene family. In man we have identified two isoforms (180 and 150 kDa) of the IF protein synemin. Synemin alpha and beta have a very short N-terminal domain of 10 amino acids and a long C-terminal domain consisting of 1243 amino acids for the alpha isoform and 931 amino acids for the beta isoform. An intronic sequence of the synemin beta isoform is used as a coding sequence for synemin alpha. Both mRNA isoforms (6.5 and 7.5 kb) result from alternative splicing of the same gene, which has been assigned to human chromosome 15q26.3. Analyses by Northern and Western blot revealed that isoform beta is the predominant isoform in striated muscles, whereas both isoforms (alpha and beta) are present in almost equal quantities in smooth muscles. Co-transfection and immunolabeling experiments indicate that both synemin isoforms are incorporated with desmin to form heteropolymeric IFs. Furthermore synemin and desmin are found aggregated together in certain pathological situations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11737198     DOI: 10.1046/j.0014-2956.2001.02594.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  18 in total

Review 1.  Intermediate filaments: primary determinants of cell architecture and plasticity.

Authors:  Harald Herrmann; Sergei V Strelkov; Peter Burkhard; Ueli Aebi
Journal:  J Clin Invest       Date:  2009-07-01       Impact factor: 14.808

2.  Synemin isoforms differentially organize cell junctions and desmin filaments in neonatal cardiomyocytes.

Authors:  Linda M Lund; Jaclyn P Kerr; Jenna Lupinetti; Yinghua Zhang; Mary A Russell; Robert J Bloch; Meredith Bond
Journal:  FASEB J       Date:  2011-10-07       Impact factor: 5.191

3.  Synemin isoforms in astroglial and neuronal cells from human central nervous system.

Authors:  A Izmiryan; E Peltekian; T Federici; D Paulin; Z L Li; Z G Xue
Journal:  Neurochem Res       Date:  2009-12-19       Impact factor: 3.996

4.  α-Synemin localizes to the M-band of the sarcomere through interaction with the M10 region of titin.

Authors:  Bethany C Prudner; Pritam Sinha Roy; Derek S Damron; Mary A Russell
Journal:  FEBS Lett       Date:  2014-11-11       Impact factor: 4.124

Review 5.  Posttranslational modifications of desmin and their implication in biological processes and pathologies.

Authors:  Daniel L Winter; Denise Paulin; Mathias Mericskay; Zhenlin Li
Journal:  Histochem Cell Biol       Date:  2013-10-04       Impact factor: 4.304

Review 6.  Defective neurofilament transport in mouse models of amyotrophic lateral sclerosis: a review.

Authors:  Mala V Rao; Ralph A Nixon
Journal:  Neurochem Res       Date:  2003-07       Impact factor: 3.996

7.  Seven kinds of intermediate filament networks in the cytoplasm of polarized cells: structure and function.

Authors:  Hirohiko Iwatsuki; Masumi Suda
Journal:  Acta Histochem Cytochem       Date:  2010-04-21       Impact factor: 1.938

8.  Hepatic stellate cells express synemin, a protein bridging intermediate filaments to focal adhesions.

Authors:  N Uyama; L Zhao; E Van Rossen; Y Hirako; H Reynaert; D H Adams; Z Xue; Z Li; R Robson; M Pekny; A Geerts
Journal:  Gut       Date:  2006-02-16       Impact factor: 23.059

9.  Intermediate filament protein synemin contributes to the migratory properties of astrocytoma cells by influencing the dynamics of the actin cytoskeleton.

Authors:  Yihang Pan; Runfeng Jing; Aaron Pitre; Briana Jill Williams; Omar Skalli
Journal:  FASEB J       Date:  2008-05-28       Impact factor: 5.191

10.  Expression of synemin in the mouse spinal cord.

Authors:  Yuji Mizuno; Jeffrey R Guyon; Koichi Okamoto; Louis M Kunkel
Journal:  Muscle Nerve       Date:  2009-05       Impact factor: 3.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.